303 PiggyBac transposon-mediated HER2-CAR-T cells exert anti-tumor efficacy against cholangiocarcinoma

• Lilin Zhang,
• Yuji Mishima,
• Shigeki Yagyu,
• Motoya Mie,
• Koichiro Shioya,
• Tomio Matsumura,
• Yuta Ohira,
• Miyuki Tanaka,
• Yozo Nakazawa

Affiliations

Lilin Zhang

1BrightPath Biotherapeutics Co., Ltd., Tokyo, Japan

Yuji Mishima

1BrightPath Biotherapeutics Co., Ltd., Kawasaki, Kanagawa, Japan

Shigeki Yagyu

Department of Paediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan

Motoya Mie

2BrightPath Biotherapeutics Co., Ltd., Chiyoda-ku, Japan

Koichiro Shioya

1BrightPath Biotherapeutics Co., Ltd., Kawasaki, Kanagawa, Japan

Tomio Matsumura

1BrightPath Biotherapeutics Co., Ltd., Kawasaki, Kanagawa, Japan

Yuta Ohira

1BrightPath Biotherapeutics Co., Ltd., Tokyo, Japan

Miyuki Tanaka

4Shinshu University School of Medicine, Matsumoto, Japan

Yozo Nakazawa

4Shinshu University School of Medicine, Matsumoto, Japan